ampicillin has been researched along with clavulanic acid in 124 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 35 (28.23) | 18.7374 |
1990's | 32 (25.81) | 18.2507 |
2000's | 31 (25.00) | 29.6817 |
2010's | 19 (15.32) | 24.3611 |
2020's | 7 (5.65) | 2.80 |
Authors | Studies |
---|---|
Hall, TW; Ishida, N; Maiti, SN; Micetich, RG; Nakai, A; Ogawa, K; Spevak, P; Tanaka, M; Yamabe, S; Yamazaki, T | 1 |
Arlet, G; Loli, A; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Cattoir, V; Corvec, S; Drugeon, H; Faccone, D; Galas, M; Mugnier, P; Nordmann, P; Pasteran, F; Petroni, A; Poirel, L; Rapoport, M | 1 |
Correia, A; Domingues, MR; Domingues, P; Fonseca, F; Henriques, I; Saavedra, MJ; Samyn, B; Sarmento, AC; van Beeumen, J | 1 |
Hawley, JS; Jorgensen, JH; Murray, CK | 1 |
Courvalin, P; Decré, D; Høiby, EA; Meziane-Cherif, D; Périchon, B | 1 |
Courvalin, P; Dupêchez, M; Galimand, M; Lambert, T; Meziane-Cherif, D | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Castanheira, M; Samuelsen, Ø; Spencer, J; Walsh, TR | 1 |
Arakawa, Y; Ishikawa, K; Nagano, N; Nagano, Y; Wachino, J | 1 |
Evenhuis, J; Griffin, M; Harbottle, H; McDermott, PF; Miller, RA; Welch, TJ; White, DG; Wise, D | 1 |
Beceiro, A; Bou, G; Cisneros, JM; Fernández-Cuenca, F; Martínez-Martínez, L; Pachón, J; Pascual, A; Pérez, A; Rodríguez-Baño, J; Vila, J | 1 |
Bonnet, R; Brisabois, A; Cloeckaert, A; Doublet, B; Fabre, L; Granier, SA; Robin, F; Weill, FX | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Ghori, S; Griggs, DJ; Johnson, MM; Mott, A; Peake, L; Piddock, LJ | 1 |
Cho, HS; Giske, CG; Lee, K; Sundman, K; Toleman, MA; Walsh, TR; Yong, D | 1 |
Girlich, D; Nordmann, P; Poirel, L | 1 |
Bethel, CR; Bonomo, RA; Distler, AM; Kasuboski, C; Papp-Wallace, KM; Taracila, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Anderson, VE; Bethel, CR; Bonomo, RA; Buynak, JD; Chen, SG; Doppalapudi, VR; Drawz, SM; Hujer, AM; Pagadala, SR; Sheri, A; Skalweit, MJ | 1 |
Bonomo, RA; Distler, AM; Endimiani, A; Hornick, JM; Hujer, AM; Hujer, KM; Papp-Wallace, KM; Taracila, M | 1 |
Nordmann, P; Poirel, L; Rodríguez-Martínez, JM; Ronco, E | 1 |
Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS | 1 |
Bethel, CR; Bonomo, RA; Caselli, E; Drawz, SM; Dwulit-Smith, JR; Papp-Wallace, KM; Prati, F; Rodkey, EA; Romagnoli, C; Smith, KM; Taracila, MA; van den Akker, F; Winkler, ML; Xu, Y | 1 |
Lewis, N; Liu, H | 1 |
Bawdon, RE; Dax, JB; Gilstrap, LC; Maberry, MC; Sobhi, S; Trimmer, KJ | 1 |
Carlin, SA; Johnson, CE; Marchant, CD; Shurin, PA | 1 |
Pastorek, JG | 1 |
Amyes, SG; Nandivada, LS | 1 |
Bergeron, MG; L'Ecuyer, J; Provencher, P; Tremblay, LD | 1 |
Sutherland, R | 1 |
Aldridge, KE; Sanders, CV | 1 |
Barry, AL; Fuchs, PC | 1 |
Renneberg, J; Walder, M | 1 |
Bruckner, G; Hampel, B; Koeppe, P; Lode, H | 1 |
Chapman, M; Colley, N; Houang, ET | 1 |
Barry, AL; Jones, RN; Packer, RR | 1 |
Aronoff, SC; Jacobs, MR; Johenning, S; Shlaes, DM; Yamabe, S | 1 |
Aronoff, SC; Jacobs, MR; Johenning, S; Yamabe, S | 2 |
Cynamon, MH; Sorg, TB | 1 |
Houben, AW; Stobberingh, EE; van Boven, CP | 1 |
Ito, T; Tamura, M | 1 |
Binder, S; Cullmann, W; Stieglitz, M | 1 |
Masecar, BL; Patterson, JE; Zervos, MJ | 1 |
Barry, AL; Fuchs, PC; Jones, RN | 1 |
Houben, AW; Stobberingh, EE; van Boven, CP; van Eck, HJ | 1 |
Gezelius, L; Liljequist, BO | 1 |
Grimm, H | 1 |
Barrier, J; Bercau, G; Ciraru-Vigneron, N; Felten, A; Leaute, JB; Nguyen Tan Lung, R; Sauvanet, E; Zylbertrest, T | 1 |
Obaseiki-Ebor, EE; Okpere, EE; Oyaide, SM | 1 |
Andrews, JM; Patel, N; Wise, R | 1 |
Li, JT; Moosdeen, F; Williams, JD | 1 |
Maskell, JP; Simpson, CN; Williams, JD | 1 |
Dominguez, M; Gonzalez, C; Merino, C; Mondaca, MA; Silva, J; Zemelman, R | 1 |
Catania, S; Ginanni Corradini, S; Iegri, F; Lorenzi, A; Martorano, E; Mascellino, MT; Prignano, G | 1 |
Gurwith, D; Gurwith, MJ; Stein, GE | 1 |
Howells, CH; Menday, AP; O'Dowd, TC; Ribeiro, CD; Smail, JE | 1 |
Li, JT; Yang, YJ | 1 |
Barry, AL; Fuchs, PC; Gavan, TL; Jones, RN; Thornsberry, C | 1 |
Feng, M; Li, JT; Ma, LJ; Tao, WY; Wang, S | 1 |
Hashimoto, T; Matsuura, M; Mitsuhashi, S; Nakazawa, H | 1 |
Coleman, K; Fisher, J; Hunter, PA; Taylor, D | 1 |
Kabat, WJ; Melick, C; Yogev, R | 1 |
Huizinga, WK; Kritzinger, NA; Robbs, JV | 1 |
Gaspar, MC; Soriano, F | 1 |
Burnham, LB; Citron, DM; Goldstein, EJ; Inderlied, CB; Kenner, MA | 1 |
Manzella, JP | 1 |
Bensoussan, F; Bensoussan, M; Bernard, E; Carsenti-Etesse, H; De Salvador, F; Dellamonica, P; Durant, J; Mondain, V; Pradier, C; Thabaut, A | 1 |
Moulis, H; Vender, RJ | 1 |
Alós, JI; Gómez-Garcés, JL; Mateos, MV | 1 |
Alarcón, MA; Campos, M; González, H; Sánchez, R | 1 |
Barry, A; Fuchs, P; Gerlach, E; Hardy, D; McLaughlin, J; Pfaller, M | 1 |
Blatter, MM; Bluestone, CD; Chan, KH; Fall, PA; Reisinger, KS; Tan, LS | 1 |
Bohman, VR; Cox, SM; Leveno, KJ; Sherman, ML | 1 |
Farinati, AE; Fernández-Lausi, A; Jugo, MB; Villar, HE | 1 |
Livermore, DM; Yuan, M | 1 |
Miller, LA; Poupard, JA; Rittenhouse, SF; Utrup, LJ | 1 |
Klepser, ME; Marangos, MN; Nicolau, DP; Nightingale, CH; Quintiliani, R; Zhu, Z | 1 |
Bonomo, RA; Rudin, SA; Shlaes, DM | 1 |
Baker, PD; Fernau, R; Landon, GC; Lipsky, BA | 1 |
Diogo, MJ; Garite, TJ; Lovett, SM; Weiss, JD; Williams, PT | 1 |
Hanaki, H; Nagayama, A; Nomura, S | 1 |
Geryk, B; Kotra, LP; Lerner, SA; Mobashery, S; Vakulenko, SB | 1 |
Das, B; Goel, V; Kapil, A; Pandey, A; Seth, P; Sood, S | 1 |
Baquero, F; Cantón, R; De Rafael, L; Martínez-Ferrer, M; Oliver, A; Pérez-Vázquez, M | 1 |
Betriu, C; Gómez, M; Palau, ML; Picazo, JJ; Sánchez, A | 1 |
Aman, K; Ebihara, M; Nakagawa, Y; Shimazu, K | 1 |
Miranda, E; Sader, HS; Sejas, L; Tosin, I | 1 |
Duff, P; Edwards, RK; Locksmith, GJ | 1 |
Amyes, SG; Bicmen, M; Gulay, Z; Yulug, N | 1 |
Fernández, F; Martínez-Martínez, L; Perea, EJ | 1 |
Azizkhan, RG; Brown, RL; Caty, MG; Gilbert, J; Glick, PL; Gollin, G; Rice, HE; Skinner, MA | 1 |
Célérier, M | 1 |
Pajchel, G; Pawłowski, K; Tyski, S | 1 |
Anderson, VE; Bethel, CR; Bonomo, RA; Helfand, MS; Hujer, AM; Hujer, KM | 1 |
Böhringer, R; Krautmacher, C; Vetter, H; Weisser, B | 1 |
Badrina, N; Benjamin, R; DeJesus, Y; Escalante, CP; Fernandez, S; Ho, V; Lam, T; Lee, EL; Manzullo, E; Rivera, E; Rolston, K; Valdres, R; Weiser, MA | 1 |
Aladueña, A; Echeíta, A; Güerri, ML; Rotger, R | 1 |
Ben Meriem, C; Ghedira Besbes, L; Guediche, MN; Messaoudi, A | 1 |
Deng, L; Deng, QL; Hu, YY; Jiang, M; Lu, Q; Shen, XZ; Yang, YH; Yu, SJ; Zhang, H | 1 |
Andre, M; Bentivoglio, G; Laus, G; Loidl, J; Ongania, KH; Schottenberger, H; Wurst, K | 1 |
Nord, CE | 1 |
Bonomo, RA; Distler, AM; Thomson, JM | 1 |
Chung, JH; Clock, CA; Ehsanipoor, RM; McNulty, JA; Wing, DA | 1 |
Harasawa, K; Kagiyama, N; Kurashima, K; Matusita, F; Miyahara, Y; Saito, H; Sugita, Y; Takayanagi, N; Tokunaga, D; Ubukata, M; Yamaguchi, S; Yanagisawa, T; Yano, R; Yoneda, K | 1 |
Hradecka, H; Kucerova, Z; Nechvatalova, K; Nedbalcova, K | 1 |
Carrascal-Camacho, AK; Mattar, S; Neuque-Rico, MC; Poutou-Piñales, RA; Ruiz-Bolivar, Z | 1 |
Jia, F; Liu, X; Wang, Y; Yang, J; Zhang, Y; Zhou, X | 1 |
Conklin, BC; Hutton, RA; Li, M; Skalweit, MJ; Taracila, MA | 1 |
Beceiro, A; Bou, G; Galleni, M; García, P; Gómez-Bertomeu, F; González-López, JJ; Kerff, F; Larrosa, N; Méndez, JA; Miró, E; Navarro, F; Oliver, A; Pérez-Llarena, FJ; Zamorano, L | 1 |
Baba, H; Hanaki, H; Sato, Y; Sunakawa, K; Toyonaga, Y | 1 |
Feng, R; Shao, C; Sun, X; Wang, P | 1 |
Mamdouh, R; Yousef, S | 1 |
Akbulut, BS; Alaybeyoglu, B; Ozkirimli, E; Uluocak, BG | 1 |
Caporali, MG; Cardines, R; Cerquetti, M; D'Ancona, F; Fabiani, M; Giufrè, M; Pezzotti, P; Riccardo, F | 1 |
Bortone, B; Hsia, Y; Sayer, B; Sharland, M | 1 |
Fekete, T | 1 |
Greisen, G; Gupta, M; Jakobsen, JC; Korang, SK; Lausten-Thomsen, U; Nava, C; Safi, S | 1 |
Ahmadvand, P; Avillan, JJ; Call, DR; Kang, C; Lewis, JA | 1 |
Hu, S; Lou, Z; Shen, Y; Tu, M | 1 |
Chaleshtori, RS; Emami, MS; Rahimi, E; Shakerian, A | 1 |
Jiang, Y; Kuang, L; Lee, M; Shi, H; Yan, L; Zhou, W | 1 |
7 review(s) available for ampicillin and clavulanic acid
Article | Year |
---|---|
Antibiotic therapy for pelvic inflammatory disease.
Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; Chlamydia Infections; Chlamydia trachomatis; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Gonorrhea; Humans; Pelvic Inflammatory Disease; Sulbactam; Ticarcillin | 1990 |
The pharmacokinetics of sultamicillin.
Topics: Amoxicillin; Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Humans; Kidney Diseases; Prodrugs; Sulbactam | 1989 |
[Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Penicillanic Acid; Penicillins; Respiratory Tract Infections; Sulbactam; Ticarcillin | 1987 |
Antibiotic-associated hemorrhagic colitis.
Topics: Adult; Aged; Amoxicillin; Ampicillin; Clavulanic Acid; Clavulanic Acids; Colitis; Female; Gastrointestinal Hemorrhage; Humans; Male; Penicillins | 1994 |
[Actinomycosis].
Topics: Actinomycosis, Cervicofacial; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Clavulanic Acid; Clindamycin; Gentamicins; Humans; Male; Prognosis; Recurrence; Time Factors; Tomography, X-Ray Computed | 2004 |
Antibiotic regimens for late-onset neonatal sepsis.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Aztreonam; Bias; Cefazolin; Clavulanic Acid; Drug Therapy, Combination; Floxacillin; Gentamicins; Humans; Infant, Newborn; Neonatal Sepsis; Randomized Controlled Trials as Topic; Ticarcillin; Vancomycin | 2021 |
Bacteriological Studies of Venomous Snakebite Wounds in Hangzhou, Southeast China.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefazolin; Cefoxitin; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Snake Bites; Sulbactam; Venoms | 2022 |
11 trial(s) available for ampicillin and clavulanic acid
Article | Year |
---|---|
Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon".
Topics: Acute Disease; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefaclor; Cefixime; Cefotaxime; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Drug Combinations; Efficiency; Enzyme Inhibitors; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella catarrhalis; Otitis Media; Punctures; Streptococcus pneumoniae; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Tympanic Membrane | 1992 |
[The drug combination amoxicillin-clavulanic acid compared to the triple combination ampicillin-gentamicin-metronidazole in the treatment of severe adnexal infections].
Topics: Amoxicillin; Ampicillin; Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Gentamicins; Humans; Metronidazole; Pelvic Inflammatory Disease; Random Allocation | 1986 |
Prospective comparison of amoxicillin-clavulanic acid and cefaclor in treatment of uncomplicated urinary tract infections.
Topics: Adult; Amoxicillin; Ampicillin; Cefaclor; Cephalexin; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Penicillin Resistance; Prospective Studies; Urinary Tract Infections | 1983 |
A comparative trial of pivmecillinam/pivampicillin and amoxycillin/clavulanate in the therapy of urinary tract infection in a general practice population.
Topics: Adult; Aged; Amdinocillin; Amdinocillin Pivoxil; Amoxicillin; Ampicillin; Bacteriuria; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Escherichia coli Infections; Female; Humans; Middle Aged; Pivampicillin; Random Allocation | 1984 |
Comparative study of sultamicillin and amoxicillin-clavulanate: treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media; Sulbactam | 1993 |
Randomized investigation of antimicrobials for the prevention of preterm birth.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Female; Gestational Age; Humans; Obstetric Labor, Premature; Penicillins; Placebos; Pregnancy; Pregnancy Outcome; Sulbactam | 1996 |
Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa.
Topics: Adult; Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Cross-Over Studies; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Female; Humans; Male; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Serum Bactericidal Test; Sulbactam; Tazobactam; Ticarcillin | 1997 |
Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clavulanic Acid; Clavulanic Acids; Diabetic Foot; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Injections, Intravenous; Male; Middle Aged; Ofloxacin; Penicillins; Prospective Studies; Sulbactam; Treatment Outcome | 1997 |
A prospective, double-blind, randomized, controlled clinical trial of ampicillin-sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy.
Topics: Adrenal Cortex Hormones; Adult; Amoxicillin; Ampicillin; Antibiotic Prophylaxis; Clavulanic Acid; Clavulanic Acids; Double-Blind Method; Drug Therapy, Combination; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Pregnancy; Pregnancy Outcome; Prospective Studies; Sulbactam | 1997 |
Results of a pilot trial comparing prolonged intravenous antibiotics with sequential intravenous/oral antibiotics for children with perforated appendicitis.
Topics: Administration, Oral; Adolescent; Ampicillin; Appendicitis; Child; Child, Preschool; Clavulanic Acid; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Humans; Injections, Intravenous; Intestinal Perforation; Male; Metronidazole; Pilot Projects; Prospective Studies; Rupture, Spontaneous | 2001 |
Outcomes of treatment pathways in outpatient treatment of low risk febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Ampicillin; Anti-Bacterial Agents; Cancer Care Facilities; Ceftazidime; Ciprofloxacin; Clavulanic Acid; Clindamycin; Critical Pathways; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome | 2004 |
106 other study(ies) available for ampicillin and clavulanic acid
Article | Year |
---|---|
Synthesis and beta-lactamase inhibitory properties of 2 beta-[(1,2,3-triazol-1-yl)methyl]-2 alpha-methylpenam-3 alpha-carboxylic acid 1,1-dioxide and related triazolyl derivatives.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Penicillanic Acid; Sulbactam; Tazobactam; Triazoles | 1987 |
SCO-1, a novel plasmid-mediated class A beta-lactamase with carbenicillinase characteristics from Escherichia coli.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillinase; Plasmids; Sequence Analysis, DNA | 2007 |
Identification of the novel narrow-spectrum beta-lactamase SCO-1 in Acinetobacter spp. from Argentina.
Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clavulanic Acid; Cloning, Molecular; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Biochemical Characterization of SFC-1, a class A carbapenem-hydrolyzing beta-lactamase.
Topics: Aztreonam; beta-Lactamases; Carbapenems; Catalysis; Cephalosporins; Clavulanic Acid; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Hydrolysis; Kinetics; Molecular Weight; Penicillanic Acid; Penicillins; Recombinant Proteins; Serratia; Sulbactam; Tazobactam | 2007 |
Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Aged; Anti-Bacterial Agents; Bacteremia; Calcaneus; Colistin; Humans; Male; Microbial Sensitivity Tests; Osteomyelitis | 2007 |
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
Topics: Amino Acid Sequence; beta-Lactams; Chromosomes, Bacterial; Cloning, Molecular; Electrophoresis, Gel, Pulsed-Field; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Infant, Newborn; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin Resistance; Penicillinase; Sequence Alignment; Sequence Analysis, DNA; Substrate Specificity | 2008 |
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Brachyspira; Cloning, Molecular; Diarrhea; Feces; Gram-Negative Bacterial Infections; Humans; Kinetics; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Sequence Analysis, DNA | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Kinetic characterization of VIM-7, a divergent member of the VIM metallo-beta-lactamase family.
Topics: Acremonium; Bacterial Proteins; beta-Lactamases; Catalysis; Catalytic Domain; Cefepime; Ceftazidime; Cephalosporins; Kinetics; Models, Molecular; Mutation; Penicillinase; Protein Structure, Tertiary; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2008 |
Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Topics: Amino Acid Sequence; beta-Lactamases; Blotting, Southern; Ceftazidime; Cephalosporins; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Homology, Amino Acid; Shigella sonnei | 2009 |
IncA/C plasmid-mediated florfenicol resistance in the catfish pathogen Edwardsiella ictaluri.
Topics: Animals; Anti-Bacterial Agents; Catfishes; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Edwardsiella ictaluri; Enterobacteriaceae Infections; Fish Diseases; Molecular Sequence Data; Plasmids; Thiamphenicol | 2009 |
Genetic variability among ampC genes from acinetobacter genomic species 3.
Topics: Acinetobacter; Acinetobacter baumannii; Amino Acid Sequence; Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; Escherichia coli; Genes, Bacterial; Genetic Variation; Humans; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sequence Homology, Amino Acid; Spain | 2009 |
Novel plasmid-encoded ceftazidime-hydrolyzing CTX-M-53 extended-spectrum beta-lactamase from Salmonella enterica serotypes Westhampton and Senftenberg.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cardiidae; Ceftazidime; Ceftriaxone; Cephalosporin Resistance; Electrophoresis, Gel, Pulsed-Field; France; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Salmonella enterica; Serotyping | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.
Topics: Amino Acid Sequence; Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Blotting, Southern; Campylobacter jejuni; Carbenicillin; Cephalosporins; Chickens; Cloxacillin; Isoelectric Focusing; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Piperacillin; Polymerase Chain Reaction; Sequence Alignment; Ticarcillin | 2009 |
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carboxylic Ester Hydrolases; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; India; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2009 |
Novel ambler class A carbapenem-hydrolyzing beta-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blotting, Southern; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Fresh Water; Gram-Negative Bacteria; Health Surveys; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas fluorescens; Water Microbiology | 2010 |
Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.
Topics: Anti-Bacterial Agents; beta-Lactamases; Catalytic Domain; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Penicillanic Acid; Spectrometry, Mass, Electrospray Ionization; Sulbactam; Tazobactam | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Penicillin sulfone inhibitors of class D beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Catalytic Domain; Cephaloridine; Cephalosporins; Enzyme Inhibitors; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Oxacillin; Penicillins; Recombinant Proteins; Substrate Specificity; Sulfones | 2010 |
Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.
Topics: Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporinase; Clavulanic Acid; Computer Simulation; Enzyme Inhibitors; Hydrogen Bonding; Kinetics; Microbial Sensitivity Tests; Molecular Structure; Mutagenesis, Site-Directed; Penicillanic Acid; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Substrate Specificity; Sulbactam; Tazobactam | 2010 |
Extended-spectrum cephalosporinase in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporinase; Cephalosporins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Mutagenesis, Site-Directed | 2010 |
Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases.
Topics: Ampicillin; beta-Lactamases; Computational Biology; Escherichia coli; Hydrogen Bonding; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Protein Structure, Secondary; Ticarcillin | 2010 |
Design and exploration of novel boronic acid inhibitors reveals important interactions with a clavulanic acid-resistant sulfhydryl-variable (SHV) β-lactamase.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Boronic Acids; Circular Dichroism; Clavulanic Acid; Crystallography, X-Ray; Drug Design; Kinetics; Microbial Sensitivity Tests; Models, Molecular; Molecular Dynamics Simulation; Mutagenesis; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Sulfhydryl Compounds | 2013 |
Comparison of ampicillin/sulbactam and amoxicillin/clavulanic acid for detection of borderline oxacillin-resistant Staphylococcus aureus.
Topics: Amoxicillin; Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Microbial Sensitivity Tests; Oxacillin; Staphylococcus aureus; Sulbactam | 1992 |
Antibiotic concentration in maternal blood, cord blood and placental tissue in women with chorioamnionitis.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefotaxime; Chorioamnionitis; Chromatography, High Pressure Liquid; Clavulanic Acid; Clavulanic Acids; Female; Fetal Blood; Humans; Placenta; Pregnancy; Regression Analysis; Sulbactam; Ticarcillin | 1992 |
Plasmid-mediated beta-lactam resistance in pathogenic gram-negative bacteria isolated in south India.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Conjugation, Genetic; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Gram-Negative Bacteria; Humans; India; Microbial Sensitivity Tests; Penicillin Resistance; R Factors | 1990 |
Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Canada; Cefaclor; Cefamandole; Cefazolin; Cefotaxime; Cefuroxime; Chloramphenicol; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Enzyme Inhibitors; Erythromycin; Haemophilus influenzae; Rifampin; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Development of beta-lactamase inhibitors.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Drugs, Investigational; Humans; Penicillins; Sulbactam; Ticarcillin | 1990 |
In vitro anaerobic data on ticarcillin/clavulanate. A review of an ongoing survey.
Topics: Ampicillin; Bacteria; Bacteroides fragilis; beta-Lactamase Inhibitors; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Clindamycin; Drug Evaluation, Preclinical; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillins; Sulbactam; Ticarcillin | 1990 |
Implications of beta-lactamase-inhibitor combinations.
Topics: Amoxicillin; Ampicillin; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Evaluation, Preclinical; Drug Therapy, Combination; Microbial Sensitivity Tests; Sulbactam; Ticarcillin | 1990 |
The role of beta-lactamase in mixed infections in mice in relation to treatment with ampicillin.
Topics: Ampicillin; Animals; Bacterial Infections; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Female; Haemophilus influenzae; Mice; Mice, Inbred BALB C; Moraxella catarrhalis; Staphylococcus aureus; Streptococcus pneumoniae | 1989 |
Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum.
Topics: Adult; Amoxicillin; Ampicillin; Ascitic Fluid; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Female; Humans; Injections, Intravenous; Kinetics; Middle Aged; Pelvis; Penicillanic Acid; Peritoneum; Sulbactam | 1985 |
In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.
Topics: Amoxicillin; Ampicillin; Bacteroides fragilis; beta-Lactamase Inhibitors; beta-Lactamases; Cefoperazone; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Penicillanic Acid; Penicillins; Sulbactam; Ticarcillin | 1986 |
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilli.
Topics: Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Gram-Negative Aerobic Bacteria; Penicillanic Acid; Penicillins; Plasmids; Sulbactam; Tazobactam | 1986 |
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads.
Topics: Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Enterobacteriaceae; Mezlocillin; Naphthyridines; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas; Sulbactam; Ticarcillin | 1986 |
Comparison of four beta-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosis.
Topics: Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Penicillanic Acid; Sulbactam | 1987 |
In vitro activity of ampicillin alone and in combination with different concentrations of 6 beta-bromopenicillanic acid, clavulanic acid and mecillinam.
Topics: Amdinocillin; Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Interactions; Drug Synergism; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillanic Acid | 1987 |
[Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Humans; Kinetics; Mezlocillin; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1987 |
Characterization and comparison of two penicillinase-producing strains of Streptococcus (Enterococcus) faecalis.
Topics: Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Synergism; Enterococcus faecalis; Gentamicins; Penicillinase; Penicillins; Phenotype; R Factors; Sulbactam | 1988 |
Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid.
Topics: Amoxicillin; Ampicillin; Bacteria, Anaerobic; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Sulbactam | 1988 |
Analysis of the relationship between ampicillin resistance and beta-lactamase production in Branhamella catarrhalis.
Topics: Ampicillin; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Isoelectric Focusing; Neisseriaceae; Penicillin Resistance; Substrate Specificity | 1986 |
In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
Topics: Amoxicillin; Ampicillin; beta-Lactamases; Cefaclor; Cefuroxime; Cephaloridine; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseriaceae; Penicillin G | 1986 |
[In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria].
Topics: Ampicillin; Ampicillin Resistance; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Sulbactam | 1987 |
Incidence of penicillinase producing Neisseria gonorrhoeae (PPNG) strains and susceptibility of gonococcal isolates to antibiotics in Benin City, Nigeria.
Topics: Ampicillin; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Nigeria; Penicillinase; Tetracycline | 1985 |
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.
Topics: Amoxicillin; Ampicillin; Bacteria; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Penicillanic Acid; Sulbactam; Tazobactam | 1984 |
6-beta-bromo- and 6-beta-iodo penicillanic acid, two novel beta-lactamase inhibitors.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Penicillanic Acid | 1981 |
The effect of inhibitors of beta-lactamases on beta-lactamase extracts and on intact cells.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cephaloridine; Clavulanic Acid; Hydrolysis; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam | 1982 |
The effect of clavulanic acid on the susceptibility of Bacteroides fragilis to three acyl-ureidopenicillins, ampicillin and carbenicillin.
Topics: Ampicillin; Azlocillin; Bacteroides fragilis; beta-Lactamases; Carbenicillin; Clavulanic Acid; Clavulanic Acids; Isoelectric Focusing; Mezlocillin; Microbial Sensitivity Tests; Piperacillin | 1984 |
Resistance of Aeromonas hydrophila to beta-lactam antibiotics.
Topics: Aeromonas; Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cephaloridine; Clavulanic Acid; Clavulanic Acids; Cloxacillin; Humans; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance | 1984 |
[Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains].
Topics: Amoxicillin; Ampicillin; beta-Lactamases; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Enterobacteriaceae; Pseudomonas | 1984 |
A study of antibacterial activity of furbenicillin against beta-lactamase producing gram-negative organisms.
Topics: Ampicillin; beta-Lactamases; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Gram-Negative Bacteria; Microbial Sensitivity Tests; Penicillins | 1984 |
In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Bacteria; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Microbial Sensitivity Tests; Quality Control; Regression Analysis | 1983 |
Initial results of in vitro studies of clavulanic acid synergism.
Topics: Ampicillin; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Carbenicillin; Clavulanic Acid; Drug Synergism; Penicillins | 1981 |
Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Clavulanic Acid; Drug Synergism; Kinetics; Penicillin Resistance | 1980 |
In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin.
Topics: Amoxicillin; Ampicillin; Bacteria; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Synergism; Humans; Penicillins; Protein Binding; Ticarcillin | 1980 |
In vitro and in vivo synergism between amoxicillin and clavulanic acid against ampicillin-resistant Haemophilus influenzae type b.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Clavulanic Acid; Drug Synergism; Drug Therapy, Combination; Haemophilus Infections; Haemophilus influenzae; Lactams; Penicillin Resistance; Rats | 1981 |
Peri-operative antibiotic cover in amputations using an amoxycillin-clavulanic acid combination.
Topics: Adult; Aged; Amoxicillin; Ampicillin; Amputation Stumps; Anti-Bacterial Agents; Clavulanic Acid; Drug Combinations; Drug Evaluation; Female; Humans; Lactams; Male; Middle Aged; Postoperative Care; Preoperative Care; Wound Infection | 1982 |
Susceptibility of Yersinia enterocolitica to eight beta-lactam antibiotics and clavulanic acid.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Clavulanic Acid; Drug Interactions; Humans; Microbial Sensitivity Tests; Penicillin G; Yersinia; Yersinia Infections | 1981 |
Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroidaceae; Child; Clarithromycin; Clavulanic Acid; Clavulanic Acids; Clostridium; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulbactam; Ticarcillin | 1995 |
Parenteral beta-lactamase inhibitor combinations for clinical use.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Sulbactam; Ticarcillin | 1995 |
Possible prevention of in vitro selection of resistant Streptococcus pneumoniae by beta-lactamase inhibitors.
Topics: Amoxicillin; Ampicillin; Ampicillin Resistance; beta-Lactam Resistance; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Multiple; Drug Synergism; Microbial Sensitivity Tests; Selection, Genetic; Streptococcus pneumoniae; Sulbactam | 1994 |
[Bacteremia by Escherichia coli resistant to amoxycillin/clavulanic acid, ampicillin/sulbactam and piperacillin/tazobactam].
Topics: Aged; Ampicillin; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Female; Humans; Penicillanic Acid; Sulbactam; Tazobactam | 1994 |
Effect of five irreversible inhibitors on beta-lactamase from Shigella flexneri UCSF-129.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Lactams; Microbial Sensitivity Tests; Penicillanic Acid; Shigella flexneri | 1993 |
Relative efficacy of tazobactam, sulbactam and clavulanic acid in enhancing the potency of ampicillin against clinical isolates of Enterobacteriaceae.
Topics: Ampicillin; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Synergism; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam | 1993 |
[Errors of the agar diffusion method to predict Escherichia coli's susceptibility to ampicillin-sulbactam and amoxicillin-clavulanic acid].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Escherichia coli; Microbial Sensitivity Tests; Predictive Value of Tests; Reproducibility of Results; Sulbactam | 1996 |
Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Humans; Intensive Care Units; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Piperacillin; Tazobactam | 1996 |
Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacter; Escherichia coli; Imipenem; Klebsiella pneumoniae; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Piperacillin; Proteus mirabilis; Pseudomonas aeruginosa; Quality Control; Reproducibility of Results; Sulbactam; Thienamycins; Ticarcillin | 1996 |
Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamases.
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Kinetics; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam | 1997 |
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections | 1997 |
Selection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase gene.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Multiple; Enzyme Inhibitors; Escherichia coli; Microbial Sensitivity Tests; Models, Molecular; Mutagenesis; Penicillins; Phenotype; Polymerase Chain Reaction | 1998 |
In vitro activities of ampicillin-sulbactam and amoxicillin-clavulanic acid against Acinetobacter baumannii.
Topics: Acinetobacter; Acinetobacter Infections; Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Clavulanic Acid; Drug Therapy, Combination; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Sulbactam | 1998 |
Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes.
Topics: Amoxicillin; Ampicillin; beta-Lactam Resistance; beta-Lactamases; Clavulanic Acid; Drug Therapy, Combination; Escherichia coli; Humans; Microbial Sensitivity Tests; Phenotype; Sulbactam | 1999 |
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoxitin; Ceftizoxime; Chloramphenicol; Clavulanic Acid; Clindamycin; Drug Therapy, Combination; Enzyme Inhibitors; Imipenem; Metronidazole; Mezlocillin; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Species Specificity; Sulbactam; Tazobactam; Thienamycins; Ticarcillin | 1999 |
[A study of beta-lactamase activity of mycobacteria and clinical trial of penicillin/beta-lactamase inhibitor combinations in the treatment of drug-resistant Mycobacterium tuberculosis].
Topics: Amoxicillin; Ampicillin; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Multiple; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Mycobacterium avium Complex; Mycobacterium chelonae; Mycobacterium tuberculosis; Penicillins; Sulbactam; Tuberculosis, Multidrug-Resistant | 1999 |
Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Clavulanic Acid; Cross Infection; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam; Ticarcillin | 2000 |
Expanded-spectrum antibiotics with preterm premature rupture of membranes.
Topics: Adult; Amoxicillin; Ampicillin; Antibiotic Prophylaxis; Chorioamnionitis; Clavulanic Acid; Endometritis; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Pregnancy; Sepsis; Ticarcillin | 2000 |
Beta-lactamase patterns and betalactam/clavulanic acid resistance in Escherichia coli isolated from fecal samples from healthy volunteers.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Clavulanic Acid; Conjugation, Genetic; Escherichia coli; Feces; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Phenotype; Plasmids | 2000 |
Relationship between haemolysis production and resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Fluoroquinolones; Gentamicins; Hemolysin Proteins; Hemolysis; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Naphthyridines; Pefloxacin; Tetracycline | 1999 |
[Caustic lesions of the esophagus in adults].
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Burns, Chemical; Caustics; Clavulanic Acid; Emergencies; Esophagectomy; Esophagostomy; Esophagus; Gastrectomy; Humans; Jejunostomy; Male; Penicillins; Time Factors; Treatment Outcome | 2001 |
CE versus LC for simultaneous determination of amoxicillin/clavulanic acid and ampicillin/sulbactam in pharmaceutical formulations for injections.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Clavulanic Acid; Drug Therapy, Combination; Electrophoresis, Capillary; Sulbactam | 2002 |
Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130.
Topics: Ampicillin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Binding, Competitive; Clavulanic Acid; Drug Resistance, Microbial; Enzyme Inhibitors; Escherichia coli; Kinetics; Models, Chemical; Mutagenesis; Mutagenesis, Site-Directed; Penicillanic Acid; Plasmids; Serine; Tazobactam; Thermodynamics; Time Factors | 2003 |
Detection of integrons and antibiotic-resistance genes in Salmonella enterica serovar Typhimurium isolates with resistance to ampicillin and variable susceptibility to amoxicillin-clavulanate.
Topics: Amoxicillin; Ampicillin; Base Sequence; Clavulanic Acid; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Humans; Infant, Newborn; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Salmonella typhi | 2004 |
[Profile of antimicrobial resistance of agents causing urinary tract infections in children].
Topics: Adolescent; Age Factors; Aminoglycosides; Amoxicillin; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Cephalosporin Resistance; Cephalosporins; Cephalothin; Child; Child, Preschool; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Infant; Klebsiella pneumoniae; Male; Penicillin Resistance; Proteus mirabilis; Retrospective Studies; Sex Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2004 |
[Surveillance of antimicrobial susceptibility of Haemophilus influenzae isolates from children in Beijing, Shanghai, and Guangzhou 2000 - 2002].
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Child, Preschool; Chloramphenicol; Clavulanic Acid; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Microbial Sensitivity Tests | 2004 |
Ionic liquids as advantageous solvents for headspace gas chromatography of compounds with low vapor pressure.
Topics: Ampicillin; Bridged Bicyclo Compounds, Heterocyclic; Butylamines; Caproates; Chromatography, Gas; Clavulanic Acid; Formamides; Imidazoles; Ions; Penicillin G Benzathine; Pressure; Solvents | 2005 |
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamase Inhibitors; Clavulanic Acid; Enzyme Inhibitors; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam | 1989 |
Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
Topics: Amino Acid Substitution; Ampicillin; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Resistance, Bacterial; Enzyme Inhibitors; Kinetics; Mass Spectrometry; Molecular Structure; Plasmids; Protein Structure, Secondary; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Sulbactam | 2007 |
A retrospective review of ampicillin-sulbactam and amoxicillin + clavulanate vs cefazolin/cephalexin and erythromycin in the setting of preterm premature rupture of membranes: maternal and neonatal outcomes.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cephalexin; Chorioamnionitis; Clavulanic Acid; Drug Therapy, Combination; Endometritis; Enterocolitis, Necrotizing; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Pregnancy; Pregnancy Outcome; Retrospective Studies; Sulbactam | 2008 |
[Case of pneumonia caused by beta-lactamase-producing and amoxicillin/clavulanate resistant strains of H. influenzae].
Topics: Aged, 80 and over; Ampicillin; beta-Lactam Resistance; beta-Lactamases; Clavulanic Acid; Community-Acquired Infections; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Pneumonia, Bacterial | 2008 |
Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolates from clinical outbreaks of porcine respiratory diseases.
Topics: Actinobacillus pleuropneumoniae; Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Clavulanic Acid; Czech Republic; Diterpenes; Genes, Bacterial; Microbial Sensitivity Tests; Swine; Swine Diseases; Tetracycline; Thiamphenicol; Tylosin | 2011 |
Antimicrobial susceptibility of Listeria monocytogenes food isolates from different cities in Colombia.
Topics: Amoxicillin; Ampicillin; Cephalosporins; Chloramphenicol; Clavulanic Acid; Colombia; Drug Resistance, Bacterial; Drug Resistance, Multiple; Food Microbiology; Listeria monocytogenes; Microbial Sensitivity Tests | 2011 |
In vitro synergistic interaction of 5-O-methylglovanon and ampicillin against ampicillin resistant Staphylococcus aureus and Staphylococcus epidermidis isolates.
Topics: Ampicillin; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Contraindications; Drug Combinations; Drug Resistance, Bacterial; Enzyme Inhibitors; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus epidermidis | 2011 |
Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance.
Topics: Amino Acid Substitution; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Biocatalysis; Cephalosporins; Clavulanic Acid; Enzyme Inhibitors; Escherichia coli; Kinetics; Meropenem; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutagenesis, Site-Directed; Structure-Activity Relationship; Substrate Specificity; Sulbactam; Thienamycins | 2012 |
Genetic and kinetic characterization of the novel AmpC β-lactamases DHA-6 and DHA-7.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Clavulanic Acid; Enterobacter cloacae; Escherichia coli; Humans; Klebsiella oxytoca; Microbial Sensitivity Tests; Penicillanic Acid; Sulbactam; Tazobactam | 2014 |
Nationwide survey of the development of drug resistance in the pediatric field in 2007, 2010, and 2012: drug sensitivity of Haemophilus influenzae serotype b strain in Japan.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clavulanic Acid; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Japan; Male; Public Health Surveillance | 2015 |
Endobronchial actinomycosis secondary to foreign body aspiration.
Topics: Actinomycosis; Aged; Ampicillin; Anti-Bacterial Agents; Bronchial Diseases; Bronchoscopy; Clavulanic Acid; Diagnosis, Differential; Doxycycline; Fiber Optic Technology; Foreign Bodies; Humans; Male | 2017 |
Class I Integron and β-lactamase encoding genes of multidrug resistance Salmonella isolated from pigeons and their environments.
Topics: Amoxicillin; Ampicillin; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Bird Diseases; Ceftazidime; Clavulanic Acid; Columbidae; Drug Resistance, Multiple, Bacterial; Egypt; Environmental Microbiology; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Salmonella; Streptomycin | 2016 |
The effect of a beta-lactamase inhibitor peptide on bacterial membrane structure and integrity: a comparative study.
Topics: Ampicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactamase Inhibitors; Cell Membrane; Cell Membrane Permeability; Cell-Penetrating Peptides; Clavulanic Acid; Drug Design; Escherichia coli; Melitten; Microbial Viability | 2017 |
Increasing trend in invasive non-typeable Haemophilus influenzae disease and molecular characterization of the isolates, Italy, 2012-2016.
Topics: Adolescent; Adult; Aged; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clavulanic Acid; Female; Genotype; Haemophilus Infections; Haemophilus influenzae; Haemophilus Vaccines; Humans; Infant; Infant, Newborn; Italy; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Serogroup; Young Adult | 2018 |
Fixed-dose combination antibiotics: The search for evidence using the example of ampicillin-cloxacillin.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Clavulanic Acid; Cloxacillin; Humans | 2021 |
Fluoroquinolones vs. amoxicillin-clavulanate or ampicillin-sulbactam were not linked to aortic aneurysm or dissection.
Topics: Amoxicillin; Ampicillin; Aortic Aneurysm; Aortic Dissection; Clavulanic Acid; Dissection; Fluoroquinolones; Humans; Sulbactam | 2021 |
Characterization of Interactions between CTX-M-15 and Clavulanic Acid, Desfuroylceftiofur, Ceftiofur, Ampicillin, and Nitrocefin.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Clavulanic Acid; Microbial Sensitivity Tests; Molecular Docking Simulation | 2022 |
Distribution of Virulence Genes in
Topics: Agaricus; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Clavulanic Acid; Erythromycin; Gentamicins; Humans; Iran; Nalidixic Acid; Virulence | 2023 |
Antibiotic Resistance of Hemophilus influenzae Isolated from Children in Southwest China.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Child; Child, Preschool; Clavulanic Acid; Drug Resistance, Microbial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Microbial Sensitivity Tests; Retrospective Studies | 2023 |